The Korean journal of internal medicine

The Korean Association of Internal Medicine (대한내과학회)
권호 표지
DOI QR코드

DOI QR Code

Combination of Uric Acid and NT-ProBNP: A More Useful Prognostic Marker for Short-Term Clinical Outcomes in Patients with Acute Heart Failure

  • Park, Hyoung-Seob (Department of Internal Medicine, Keimyung University School of Medicine) ;
  • Kim, Hyung-Seop (Department of Internal Medicine, Keimyung University School of Medicine) ;
  • Sohn, Ji-Hyun (Department of Internal Medicine, Keimyung University School of Medicine) ;
  • Shin, Hong-Won (Department of Internal Medicine, Keimyung University School of Medicine) ;
  • Cho, Yun-Kyeong (Department of Internal Medicine, Keimyung University School of Medicine) ;
  • Yoon, Hyuck-Jun (Department of Internal Medicine, Keimyung University School of Medicine) ;
  • Nam, Chang-Wook (Department of Internal Medicine, Keimyung University School of Medicine) ;
  • Hur, Seung-Ho (Department of Internal Medicine, Keimyung University School of Medicine) ;
  • Kim, Yoon-Nyun (Department of Internal Medicine, Keimyung University School of Medicine) ;
  • Kim, Kwon-Bae (Department of Internal Medicine, Keimyung University School of Medicine) ;
  • Park, Hee-Joon (Department of Medical Informatics, Keimyung University School of Medicine)
  • Received : 2009.05.23
  • Accepted : 2010.01.05
  • Published : 2010.09.01
⟨ Previous Next ⟩

Abstract

Background/Aims: In patients with heart failure (HF), N-terminal prohormone brain natriuretic peptide (NT-ProBNP) is a standard prognostic indicator. In addition, uric acid (UA) was recently established as a prognostic marker for poor outcome in chronic HF. The aim of this study was to determine the combined role of UA and NT-ProBNP as prognostic markers for short-term outcomes of acute heart failure (AHF). Methods: The levels of UA and NT-ProBNP were determined in 193 patients (age, $69{\pm}13$ years; 76 males) admitted with AHF. Patients were followed for 3 months and evaluated for cardiovascular events, defined as cardiac death and/or readmission for HF. Results: Of the 193 patients, 23 (11.9%) died and 20 (10.4%) were readmitted for HF during the 3-month followup period. Based on univariate analysis, possible predictors of short-term cardiovascular events were high levels of UA and NT-ProBNP, low creatinine clearance, no angiotensin converting enzyme inhibitors or angiotensin receptor blockers, and old age. Multivariate Cox hazard analysis showed that UA levels were independently associated with increased incidence of cardiovascular events (hazard ratio, 1.115; 95% confidence interval, 1.006 to 1.235; p = 0.037). Kaplan-Meier survival analysis revealed that patients with UA levels > 8.0 mg/dL and NT-ProBNP levels > 4,210 pg/mL were at highest risk for cardiac events (p = 0.01). Conclusions: The combination of UA and NT-ProBNP levels appears to be more useful than either marker alone as an independent predictor for short-term outcomes in patients with AHF.

Keywords

References

  1. Lainchbury JG, Campbell E, Frampton CM, et al. Brain natriuretic peptide and n-terminal brain natriuretic peptide in the diagnosis of heart failure in patients with acute shortness of breath. J Am Coll Cardiol 2003;42:728-735. https://doi.org/10.1016/S0735-1097(03)00787-3
  2. Song BG, Jeon ES, Kim YH, et al. Correlation between levels of Nterminal pro-B-type natriuretic peptide and degrees of heart failure. Korean J Intern Med 2005;20:26-32. https://doi.org/10.3346/jkms.2005.20.1.26
  3. Bettencourt P, Azevedo A, Pimenta J, et al. N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients. Circulation 2004;110:2168-2174. https://doi.org/10.1161/01.CIR.0000144310.04433.BE
  4. Gardner RS, Ozalp F, Murday AJ, et al. N-terminal pro-brain natriuretic peptide. A new gold standard in predicting mortality in patients with advanced heart failure. Eur Heart J 2003;24:1735-1743. https://doi.org/10.1016/j.ehj.2003.07.005
  5. Freedman DS, Williamson DF, Gunter EW, et al. Relation of serum uric acid to mortality and ischemic heart disease: the NHANES I epidemiologic follow-up study. Am J Epidemiol 1995;141:637-644.
  6. Fang J, Alderman MH. Serum uric acid and cardiovascular mortality: the NHANES I epidemiologic follow-up study, 1971- 1992. National Health and Nutrition Examination Survey. JAMA 2000;283:2404-2410. https://doi.org/10.1001/jama.283.18.2404
  7. Niskanen LK, Laaksonen DE, Nyyssönen K, et al. Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: a prospective cohort study. Arch Intern Med 2004;164:1546-1551. https://doi.org/10.1001/archinte.164.14.1546
  8. Verdecchia P, Schillaci G, Reboldi G, et al. Relation between serum uric acid and risk of cardiovascular disease in essential hypertension: the PIUMA study. Hypertension 2000;36:1072-1078. https://doi.org/10.1161/01.HYP.36.6.1072
  9. Mazza A, Pessina AC, Pavei A, et al. Predictors of stroke mortality in elderly people from the general population: the cardiovascular study in the elderly. Eur J Epidemiol 2001;17:1097-1104. https://doi.org/10.1023/A:1021216713504
  10. Weir CJ, Muir SW, Walters MR, et al. Serum urate as an independent predictor of poor outcome and future vascular events after acute stroke. Stroke 2003;34:1951-1956. https://doi.org/10.1161/01.STR.0000081983.34771.D2
  11. Bos MJ, Koudstaal PJ, Hofman A, et al. Uric acid is a risk factor for myocardial infarction and stroke: the Rotterdam study. Stroke 2006;37:1503-1507. https://doi.org/10.1161/01.STR.0000221716.55088.d4
  12. Anker SD, Doehner W, Rauchhaus M, et al. Uric acid and survival in chronic heart failure: validation and application in metabolic, functional, and hemodynamic staging. Circulation 2003;107:1991-1997. https://doi.org/10.1161/01.CIR.0000065637.10517.A0
  13. Nieminen MS, Bohm M, Cowie MR, et al. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J 2005;26:384-416. https://doi.org/10.1093/eurheartj/ehi044
  14. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41. https://doi.org/10.1159/000180580
  15. Leyva F, Chua TP, Anker SD, et al. Uric acid in chronic heart failure: a measure of the anaerobic threshold. Metabolism 1998;47:1156-1159. https://doi.org/10.1016/S0026-0495(98)90293-1
  16. Leyva F, Anker S, Swan JW, et al. Serum uric acid as an index of impaired oxidative metabolism in chronic heart failure. Eur Heart J 1997;18:858-865. https://doi.org/10.1093/oxfordjournals.eurheartj.a015352
  17. Doehner W, von Haehling S, Anker SD. Uric acid as a prognostic marker in acute heart failure: new expectations from an old molecule. Eur J Heart Fail 2007;9:437-439. https://doi.org/10.1016/j.ejheart.2007.03.006
  18. Sakai H, Tsutamoto T, Tsutsui T, et al. Serum level of uric acid, partly secreted from the failing heart, is a prognostic marker in patients with congestive heart failure. Circ J 2006;70:1006-1011. https://doi.org/10.1253/circj.70.1006
  19. Cappola TP, Kass DA, Nelson GS, et al. Allopurinol improves myocardial efficiency in patients with idiopathic dilated cardiomyopathy. Circulation 2001;104:2407-2411. https://doi.org/10.1161/hc4501.098928
  20. Cingolani HE, Plastino JA, Escudero EM, et al. The effect of xanthine oxidase inhibition upon ejection fraction in heart failure patients: La Plata Study. J Card Fail 2006;12:491-498. https://doi.org/10.1016/j.cardfail.2006.05.005
  21. Struthers AD, Donnan PT, Lindsay P, et al. Effect of allopurinol on mortality and hospitalisations in chronic heart failure: a retrospective cohort study. Heart 2002;87:229-234. https://doi.org/10.1136/heart.87.3.229
  22. Pascual-Figal DA, Hurtado-Martínez JA, Redondo B, et al. Hyperuricaemia and long-term outcome after hospital discharge in acute heart failure patients. Eur J Heart Fail 2007;9:518-524. https://doi.org/10.1016/j.ejheart.2006.09.001
  23. Landmesser U, Spiekermann S, Dikalov S, et al. Vascular oxidative stress and endothelial dysfunction in patients with chronic heart failure: role of xanthine-oxidase and extracellular superoxide dismutase. Circulation 2002;106:3073-3078. https://doi.org/10.1161/01.CIR.0000041431.57222.AF
  24. Anand IS, Fisher LD, Chiang YT, et al. Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT). Circulation 2003;107:1278-1283. https://doi.org/10.1161/01.CIR.0000054164.99881.00
  25. Maeda K, Tsutamoto T, Wada A, et al. High levels of plasma brain natriuretic peptide and interleukin-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure. J Am Coll Cardiol 2000;36:1587-1593. https://doi.org/10.1016/S0735-1097(00)00912-8
  26. Anwaruddin S, Lloyd-Jones DM, Baggish A, et al. Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study. J Am Coll Cardiol 2006;47:91-97. https://doi.org/10.1016/j.jacc.2005.08.051

Cited by

  1. Upstream therapies after pulmonary vein ablation: five negative studies--what's next? vol.12, pp.11, 2010, https://doi.org/10.1093/europace/euq402
  2. The role of brain natriuretic peptide and NT- probrain natriuretic peptide in diagnostics of chronic heart failure and asymptomaticleft ventricular dysfunction in patients with type 2 diabetes mellitu vol.14, pp.3, 2010, https://doi.org/10.14341/2072-0351-6221
  3. Prognostic markers for acute heart failure vol.7, pp.4, 2010, https://doi.org/10.1517/17530059.2013.814638
  4. Comparison of Prognostic Value of Red Cell Distribution Width and NT-proBNP for Short-Term Clinical Outcomes in Acute Heart Failure Patients vol.55, pp.1, 2010, https://doi.org/10.1536/ihj.13-172
  5. BNP and NT-proBNP as prognostic markers in persons with acute decompensated heart failure: a systematic review vol.19, pp.4, 2010, https://doi.org/10.1007/s10741-014-9442-y
  6. Liver Enzymes and Uric acid in Acute Heart Failure vol.4, pp.4, 2010, https://doi.org/10.5812/cardiovascmed.4(2)2015.22988
  7. Prognostic value of serum uric acid in patients with acute heart failure : A meta-analysis vol.98, pp.8, 2010, https://doi.org/10.1097/md.0000000000014525
  8. Prognostic value of prealbumin, N-terminal pro-B-type natriuretic peptide, heart type fatty acid binding protein, and cardiac troponin I in elderly patients for heart failure and poor outcomes vol.49, pp.5, 2010, https://doi.org/10.1177/0300060521999742